1991
DOI: 10.1016/0014-2999(91)90824-a
|View full text |Cite
|
Sign up to set email alerts
|

DesArg9D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin (desArg10-[Hoe140]) is a bradykinin B1 receptor antagonist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
24
0

Year Published

1995
1995
2005
2005

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(25 citation statements)
references
References 6 publications
1
24
0
Order By: Relevance
“…The affinity of [Leu8,des-Arg']-BK in these two preparations is lower than its affinity reported previously in the rabbit aorta (pA2 6.8; Regoli et al, 1978) and mesenteric artery (pA2 6.5; Churchill & Ward, 1986 (Regoli & Barab6, 1980;Butt et al, 1994a,b), and no complication in interpretation due to differences between species needs to be taken into account (see Hall, 1992;Hall et al, 1993). The novel B1 receptor antagonist [des-Arg'I-Hoel40 (Wirth et al, 1991) has a ten fold higher affinity than [Leu8,des-Argl-BK.…”
Section: Phosphatidylinositol Hydrolysis Measurementmentioning
confidence: 73%
“…The affinity of [Leu8,des-Arg']-BK in these two preparations is lower than its affinity reported previously in the rabbit aorta (pA2 6.8; Regoli et al, 1978) and mesenteric artery (pA2 6.5; Churchill & Ward, 1986 (Regoli & Barab6, 1980;Butt et al, 1994a,b), and no complication in interpretation due to differences between species needs to be taken into account (see Hall, 1992;Hall et al, 1993). The novel B1 receptor antagonist [des-Arg'I-Hoel40 (Wirth et al, 1991) has a ten fold higher affinity than [Leu8,des-Argl-BK.…”
Section: Phosphatidylinositol Hydrolysis Measurementmentioning
confidence: 73%
“…HPP‐des‐Arg 10 ‐Hoe 140 (3‐4 hydroxyphenyl‐propionyl‐desArg 9 ‐D‐Arg°‐[Hyp 3 , Thi 5 , D‐Tic 7 , Oic 8 ]‐bradykinin [BK]) and HPP‐Hoe 140 (3‐4 hydroxyphenyl‐propionyl‐D‐Arg°‐[Hyp 3 , Thi 5 , D‐Tic 7 , Oic 8 ]‐BK) were developed from the selective B 1 receptor antagonist desArg 10 ‐Hoe 140 (Wirth et al, 1991) and the B 2 receptor antagonist Hoe 140 or Icatibant (Hock et al, 1991), respectively. They were synthesized in the laboratory of D. Regoli (Department of Pharmacology, Université de Sherbrooke, Canada).…”
Section: Methodsmentioning
confidence: 99%
“…It has been proposed that BK receptor classification should be extended to include B 3 subtypes (Farmer et al 1989a,b, Hall 1997 as the presence of B 3 receptors has been demonstrated in guinea-pig trachea and taenia caeci (Field et al 1992a,b). BK is a potent B 2 receptor agonist (Regoli & Barabé 1980, Hall 1992) with HOE-140 being a potent and selective B 2 receptor antagonist (Wirth et al 1991a,b, Hock et al 1991. Des-Arg 9 -BK is a potent B 1 receptor agonist (Regoli & Barabé 1980, Hall 1992 with des-Arg 9 (leu 8 )BK reported to be a selective B 1 receptor antagonist (Churchill & Ward 1986, Field et al 1992a, Hall 1992, Campos & Calixto 1994, Drummond & Cocks 1995.…”
Section: Introductionmentioning
confidence: 99%